Pfizer Inc.
27.78USD
-0.0100 (-0.04%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15,034 | 14,451 | 17,557 | 16,654 | 14,653 | 13,715 | 17,763 | 17,702 |
| Cost of Revenue | 4,092 | 3,548 | 5,272 | 4,172 | 3,778 | 2,845 | 5,909 | 5,263 |
| Gross Profit | 10,942 | 10,903 | 12,285 | 12,482 | 10,875 | 10,870 | 11,854 | 12,439 |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | -248 | 2,687 | -1,648 | 3,541 | 2,910 | 2,967 | 410 | 4,465 |
| EPS (Diluted) | $-0.04 | $0.47 | $-0.29 | $0.62 | $0.51 | $0.52 | $0.07 | $0.78 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)